Nucleolar PARP-1 Expression Is Decreased in Alzheimer’s Disease: Consequences for Epigenetic Regulation of rDNA and Cognition

Table 2

CA1.

	% of pyramidal; cells nucleoli	Mean	-test
Control; Alzheimer’s	PARP1(+)/Fib(+)	58.80; 29.74	0.039 ()
Control; Alzheimer’s	PARP1(+)/Fib(−)	7.17; 2.53	0.329
Control; Alzheimer’s	PARP1(−)/Fib(+)	6.05; 21.52	0.024 ()
Control; Alzheimer’s	Total PARP1(+)	68.60; 32.27	0.017 ()
Control; Alzheimer’s	Total Fib(+)	64.85; 51.69	0.242

⁢.